Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **gut microbial ecosystem and host immune system** constitute a dynamic, interdependent network where trillions of microbes interact with the host’s innate and adaptive immune components through direct cell contact and vast arrays of metabolites. This crosstalk is fundamental to health, affecting nutrient absorption, epithelial barrier function, immune development, and protection against pathogens. Disruptions in these interactions (“dysbiosis”) can result in inflammation, autoimmunity, metabolic disturbances, infection, and even influence cancer progression and therapeutic outcomes. The ecosystem is so complex that targeting the entire system pharmacologically is not practical; instead, research is focused on modifying specific microbiota members, their metabolites, or host immune pathways.
Modulation of microbial composition and metabolite production (probiotics, FMT, antibiotics); Regulation of host immune cell (T cell, B cell, dendritic cell) differentiation via microbial metabolites (SCFAs, ATP, polysaccharides); Restoration of epithelial barrier integrity; Enhancement or suppression of inflammatory responses
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbial ecosystem and host immune system.